Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Future SP

I give the following more as an approach to a calculation than as an accurate one.

Assume no interest or taxation impacts.

Assume $800M in future license revenues.

TPL gets 15% off the top, $120M, leaving $680M to be split 50/50 by PDS yielding $340M to PTSC. That's about 83c per PTSC share - call it 80c after overheads, professional fees, board fees, board expenses and at least one more SHAM..

So if all the licenses were received on the same day a dividend of 80c per share could be paid - end of. Thus, to my mind, at any future time the SP would be no more than 80c less any dividends paid out.

Of course, if the BOD were to again skillfully invest the $340M "in the best interests of the company and its shareholders" then the potential dividends would be much less.

Plug in you own numbers.


Feb 04, 2012 03:41AM

Feb 04, 2012 09:20AM
3
Feb 04, 2012 10:42AM
4
Feb 04, 2012 11:36AM
13
Feb 04, 2012 12:32PM
4
Feb 04, 2012 01:36PM
2
Feb 05, 2012 03:09PM
2
Feb 05, 2012 03:35PM
1
Feb 05, 2012 04:54PM
3
Feb 05, 2012 04:59PM

Feb 05, 2012 06:24PM
2
Feb 05, 2012 06:44PM
2
Feb 06, 2012 03:57AM
3
Feb 06, 2012 05:13AM
1
Feb 06, 2012 06:21AM
5
Feb 06, 2012 07:36AM
Share
New Message
Please login to post a reply